News
Regardless of the outcome of the Trump-Putin meeting, SPI Asset Management's Innes said the summit wasn't "a magic lever for supply." That's because "Russian output isn't only capped by sanctions - it ...
Under Armour Lacks Competitive Advantage, but Association With Global Athletics Provides Opportunity
Under Armour has had problems in both its direct-to-consumer and wholesale businesses. Although annual sales through its direct-to-consumer channels increased to about $2.1 billion in fiscal 2025 from ...
Amid a strong quarter of earnings results, Morningstar analysts have been bumping up their fair value estimates for a wide ...
Applied Materials’ AMAT fiscal third-quarter results met management guidance, but management expects a decline next quarter.
The Chinese economy lost some momentum in July, backing the case for policymakers to snap out of wait-and-see mode and stimulate growth. Japan's latest economic data has calmed recession fears, ...
A super-duper first-world problem incoming. My spouse and I ( 51 and 59) have a household net worth of around $11 million, which includes oversized college funds for our two teenagers. We have retired ...
The effects from U.S. tariffs as well as headwinds from foreign exchange and commodity prices were expected to increase, the Danish jeweler said. Airfares rose in July for the first time since January ...
Taylor Swift announced that her next record, "The Life of a Showgirl," will be released on Oct. 3. Lukas Alpert explained how important Swift's new release will be to the entire recording industry.
Intel Corp. finds itself in an uncomfortable and unfamiliar position: While the chipmaking giant undergoes a painful restructuring under new CEO Lip-Bu Tan, its rivals are mounting their most ...
Dollar/Canadian dollar: 1.3820 Canadian dollars per dollar (0.7236 dollar per Canadian dollar) ...
In a statement Friday, Opendoor (OPEN) said that Chief Executive Carrie Wheeler, who also chaired the company's board, was stepping down from her roles effective immediately. Shrisha Radhakrishna, the ...
The new approval allows the GLP-1 to be used to treat adults with the liver disease metabolic dysfunction-associated steatohepatitis (MASH) and liver scarring. Wegovy is the first GLP-1 to receive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results